OMRON : Financial Statements (20251107 financial results)

November 7, 2025

Exchanges Listed: Tokyo

URL: https://www.omron.com/global/en/

Representative: Junta Tsujinaga, President and CEO

Contact: Toyoharu Tamoi, Executive Officer, Senior General Manager, Global Finance and Accounting HQ

Telephone: +81-75-344-7070

Filing of Interim Securities Report (Hanki hokokusho)

(scheduled): November 14, 2025

Start of Distribution of Dividends (scheduled): December 2, 2025 Preparation of Supplementary Materials for the Interim

Financial Results: Yes

Holding of Presentation of Interim Financial Results: Yes (for investors)

Note: Figures are rounded to the nearest million yen.

1. Consolidated Financial Results for the Second Quarter (First Half) of the Fiscal Year Ending March 31, 2026 (April 1, 2025 - September 30, 2025)

   1. Sales and Income (cumulative) (Percentages represent changes compared with the same period of the previous fiscal year.)

      	Net sales		Operating income		Income (loss) before income taxes	Net income (loss) attributable to shareholders
      Six months ended	Million yen	%	Million yen	%	Million yen %	Million yen	%
      September 30, 2025	393,448	5.0	17,719	(7.8)	17,035 －	9,047	-
      September 30, 2024	374,638	(6.5)	19,226	(6.9)	(336) －	(3,318)	-

      Notes: Comprehensive income: Six months ended September 30, 2025: JPY18,273 million (－% change); Six months ended September 30, 2024: JPY(12,542) million (－% change)

      	Net income (loss) per share attributable to OMRON shareholders, basic	Net income per share attributable to OMRON shareholders, diluted
      Six months ended	Yen	Yen
      September 30, 2025	45.96	-
      September 30, 2024	(16.86)	-

   2. Consolidated Financial Position

      	Total assets	Net assets	Shareholders' equity	Shareholders' equity ratio
      	Million yen	Million yen	Million yen	%
      September 30, 2025	1,399,661	940,292	777,807	55.6
      March 31, 2025	1,361,790	934,432	771,885	56.7

2. Dividends

   	Dividends per share
   	First quarter-end	First half-end	Third quarter-end	Fiscal year-end	Total
   Fiscal year ended March 31, 2025 Fiscal year ending March 31, 2026	Yen	Yen	Yen	Yen	Yen
   	- -	52.00 52.00	-	52.00	104.00
   Fiscal year ending March 31, 2026 (projected)			-	52.00	104.00

   Note: Revisions since the most recently announced dividend forecast: Yes

   The Company has decided to pay an interim dividend of 52.00 yen per share for the fiscal year ending March 31, 2026. In addition, the Company has not changed the annual dividend forecast, including the year-end dividend. For more, see 1.

   Qualitative Information on Interim Financial Results (4) Determination of Dividends (Interim Dividend) and Revision of Year-End Dividend Forecast on P.9 in the attached materials.

3. Projected Results for the Year Ending March 31, 2026 (April 1, 2025 - March 31, 2026)

(Percentages represent changes compared with the same period of the previous fiscal year.)

Note: Revisions since the most recently announced performance forecast: Yes

For more, see 1. Qualitative Information on Interim Financial Results (3) Description of Information on Outlook, Including Consolidated Performance Forecast on P.6 of the attached materials.

*Notes

1. Significant changes in the scope of consolidation during the period: No New: - company (company name) Excluded: - company (company name)

2. Application of simplified accounting methods and/or special accounting methods: No

3. Changes in accounting policy

   1. Changes in accounting policy accompanying revision of accounting standards, etc.: No

   2. Changes in accounting policy other than (a) above: No

4. Number of shares issued and outstanding

1. Number of shares outstanding at period-end (including treasury stock)

2. Treasury stock at period-end

3. Average number of shares during the period (quarterly cumulative)

Table of Contents

1. Qualitative Information on Interim Financial Results… P.2

   1. Description of Results of Operations……………………………………………………………………………………… P.2

   2. Analysis of Financial Condition…………………………………………………………………………………………… P.6

   3. Description of Information on Outlook, Including Consolidated Performance Forecast ………………………………… P.6

   4. Determination of Dividends (Interim Dividend) and Revision of Year-End Dividend Forecast ………………………… P.9

2. Interim Consolidated Financial Statements and Notes ……………………………………………………………………… P.10

   1. Interim Consolidated Balance Sheets …………………………………………………………………………………… P.10

   2. Interim Consolidated Statements of Income and Interim Consolidated Statements of Comprehensive Income …….. P.12

   3. Interim Consolidated Statements of Cash Flows ………………………………………………………………………… P.14

   4. Notes Regarding Consolidated Financial Statements …………………………………………………………………… P.15 (Notes Regarding Assumptions of Going Concern) …………………………………………………………………… P.15 (Notes in the Event of Significant Changes in Shareholders' Equity) ………………………………………………… P.15 (Segment Information) ………………………………………………………………………………………………… P.16

1. Qualitative Information on Interim Financial Results
   1. Description of Results of Operations General Overview

      OMRON Group financial performance for the interim period of the current consolidated fiscal year (April to September, 2025) showed an increase in net sales and a decrease in operating income year on year; however, net sales and operating income outperformed our initial projections.

      Net sales in the Healthcare Business were lower year on year; however, net sales rose overall due to our steady capture of the recovery semiconductor- and other-related demand in the Industrial Automation Business and Devices & Module Solutions Business.

      Operating income decreased year on year, even with higher net sales and the positive impact of fixed cost improvements under Structural Reform Program NEXT 2025. Soaring raw materials costs, increased logistics costs, and U.S. tariff policy had a negative impact on gross profit margin, while we investment in development for the future also had a negative impact on operating income.

      Further, income before income taxes and net income attributable to OMRON shareholders increased significantly compared to the same period in the previous fiscal year, when we posted one-time expenses related to headcount and capacity optimization.

      Consolidated results for the current consolidated interim period were as follows.

      (Billions of yen, except exchange rate data and percentages)

      	Six months ended September 30, 2024	Six months ended September 30, 2025	Change
      Net sales	374.6	393.4	+5.0%
      Gross profit [% of net sales]	170.0 [45.4%]	172.5 [43.9%]	+1.5% [-1.5%pt]
      Operating income [% of net sales]	19.2 [5.1%]	17.7 [4.5%]	-7.8% [-0.6%pt]
      Income (loss) before income taxes	(0.3)	17.0	-
      Net income (loss) attributable to OMRON shareholders	(3.3)	9.0	-
      Average USD exchange rate (Yen)	153.7	146.4	(7.3)
      Average EUR exchange rate (Yen)	166.3	166.8	+0.5
      Average CNY exchange rate (Yen)	21.2	20.3	(0.9)

      Results by Business Segment IAB (Industrial Automation Business)

      (Billions of yen, %)

      	Six months ended September 30, 2024	Six months ended September 30, 2025	Change
      Sales to external customers	174.5	188.8	+8.2%
      Operating income	17.4	18.8	+8.5%

      Sales

      While we did not see a substantial recovery in capital investment demand in the manufacturing sector, the OMRON Group steadily captured investment demand in China for semiconductor AI-related investment and rechargeable battery-related investment through our efforts to strengthen partnerships with distributors by restructuring supply chains and stepping up new product development, resulting in higher sales year on year.

      Operating Income

      Operating income increased year on year, despite the impact of U.S. tariff policy and rising logistics costs, as net sales increased and we improved fixed costs.

      HCB (Healthcare Business)

      (Billions of yen, %)

      	Six months ended September 30, 2024	Six months ended September 30, 2025	Change
      Sales to external customers	72.5	66.7	-8.0%
      Operating income	8.6	5.7	-33.8%

      Sales

      Sales of mainstay blood pressure monitors increased year on year in Asia, North America, Europe, and other regions. However, sales overall decreased due to continued sluggish consumption in China. The increase in the second quarter (July-September 2025) compared to the year-ago period was mainly due to efforts to strengthen competitiveness in China.

      Operating Income

      Despite the ongoing impact of the U.S. tariff policy during the second quarter, operating income improved as a result of higher sales compared to the year-ago period and the impact of a review of our fixed cost structure. However, operating income decreased significantly for the interim period of the current consolidated fiscal year due to the impact of a decrease in sales compared to the first quarter in the previous fiscal year (April to June 2025).

      SSB (Social Systems, Solutions and Service Business)

      (Billions of yen, %)

      	Six months ended September 30, 2024	Six months ended September 30, 2025	Change
      Sales to external customers	56.9	57.7	+1.4%
      Operating income	2.0	2.8	+41.9%

      Sales

      The Energy Solutions Business continued to experience firm results in response to soaring energy prices pushing needs for captive consumption of renewable energy in the housing field. The impact of the use of subsidies in advance also contributed to solid performance. Customer demand for capital investment remained stable in the Public Transportation System Business. As a result of these factors, sales increased year on year.

      Operating Income

      Operating income increased significantly year on year, mainly due to the increase in sales, as well as the impact of efforts to reduce variable costs.

      DMB (Devices & Module Solutions Business)

      (Billions of yen, %)

      	Six months ended September 30, 2024	Six months ended September 30, 2025	Change
      Sales to external customers	51.1	56.6	+10.8%
      Operating income	0.1	1.3	-

      Sales

      Sales to the consumer industry increased globally due to continued demand growth in the semiconductor-related and energy sectors, mainly driven by AI demand. At the same time, despite firm demand for motorcycles in Asia, sales remained nearly flat, owing in part to revisions to preferential treatment for electric vehicles in Europe. As a result of the preceding, sales increased significantly year on year.

      Operating Income

      Operating income increased significantly year on year, despite the impact of higher raw materials prices and rising logistics costs, as net sales increased and we improved manufacturing fixed cost ratio.

      DSB (Data Solution Business)

      (Billions of yen, %)

      	Six months ended September 30, 2024	Six months ended September 30, 2025	Change
      Sales to external customers	19.1	22.9	+20.0%
      Operating Income	0.3	0.8	+125.1%

      Note: The Data Solution Business includes financial figures related to the OMRON Data Solution Business and financial results of JMDC, Inc. ("JMDC"), as well as the amortization of intangible assets other than goodwill identified when making JMDC a consolidated subsidiary.

      Sales

      The number of contracted health insurance associations and the number of IDs issued for the JMDC health information platform Pep Up increased during the period. Transactions with pharmaceutical companies and insurance companies that utilize anonymously processed data from health insurance associations and medical institutions also increased. As a result of the preceding, sales increased significantly year on year.

      Operating Income

      Despite steady investments for establishing the Data Solution Business, JMDC reported solid operating income, resulting in significant year-on-year growth in segment operating income.

   2. Analysis of Financial Condition

      Total assets as of the end of the consolidated second quarter amounted to JPY1,399.7 billion, an increase of JPY37.9 billion compared to the end of the previous consolidated fiscal year. This result was mainly due to an increase in inventories, cash and cash equivalents, and investment securities. Total liabilities amounted to JPY459.4 billion, an increase of JPY32.0 billion compared to the end of the previous fiscal year. This result was mainly due to an increase in Short-term debt. Total net assets amounted to JPY940.3 billion, an increase of JPY5.9 billion compared to the end of the previous consolidated fiscal year. This result was mainly due to an increase in foreign currency translation adjustments. Shareholders' equity ratio was 55.6%, demonstrating an ongoing strong financial foundation.

      In terms of liquidity, cash on hand amounted to JPY160.6 billion. Further, we have signed commitment line agreements with financial institutions in the amount of JPY70.0 billion. We intend to maintain high credit ratings from ratings agencies as a long-term issuer, and we secure liquidity and funding capacity while maintaining our ability to raise funds and good relationships with financial institutions on a global basis.

   3. Description of Information on Outlook, Including Consolidated Performance Forecast

      Our full-year performance forecast announced May 8, 2025 ("initial forecast") disclosed net sales and profit measurements as a range of results in response to uncertainty in the direction of U.S. tariff policy trend and the difficulty in foreseeing the impact on earnings. However, the impact of this policy has become sufficiently clear to allow us to present forecasts as specific numbers.

      We expect the business environment of the third quarter and beyond to be generally in line with our assumptions at the beginning of the fiscal year. We expect full-year net sales to be JPY845 billion (+5.4% year on year), which exceeds the upper end of the range of our initial forecast. This forecast reflects factors including the fact that interim consolidated performance exceeded forecasts. We expect operating income to be JPY60 billion (+11.0% year on year), which is within the range of the initial forecast. This forecast assumes that we will minimize the impact of the U.S. tariff policy through higher selling prices and other measures. At the same time, we expect raw material prices and logistics costs to continue to rise, while we intend to make investments in development for growth as planned at the beginning of the period.

      We have changed our exchange rate assumptions for the third quarter and beyond to USD1 = JPY145, EUR1

      = JPY165, and CNY1 = JPY20.

      The following describes our main expectations for the business environment in connection with each business segment for the third quarter and beyond.

      Industrial Automation Business	AI-related demand in the semiconductor industry will remain strong, as we assumed in our initial forecast. At the same time, we expect sales for electric vehicles to remain sluggish.
      Healthcare Business	As expected generally at the beginning of the period, the blood pressure meter market remained firm globally; however, we expect results in China to be level with the previous fiscal year.
      Social Systems, Solutions and Service Business	We expect performance in the business to be in line with our initial forecast.
      Devices & Module Solutions Business	We expect the business environment to remain solid, in line with initial forecast.
      Data Solution Business	Firm business environment will continue in line with our initial forecast, particularly in the health big data business.

      Projected Consolidated Performance

      (Billions of yen, except percentages)

      	Initial forecast	Revised forecast (A)	Change vs. initial forecast [% change]	(Reference) Actual results for the prior fiscal yearended March 31 ,2025 (B)	(Reference) Percentage change from the prior fiscal year [ ] indicates change from the prior fiscal year
      Net sales	835.0~ 820.0	845.0	+10.0~+25.0 [+1.2~+3.0%]	801.8	+5.4%
      Operating income	65.0~ 56.0	60.0	(5.0)~+4.0 [-7.7~+7.1%]	54.0	+11.0%
      Income before income taxes	58.0~ 49.0	54.5	(3.5)~+5.5 [-6.0~+11.2%]	29.0	+87.9%
      Net income attributable to OMRON shareholders	35.5~ 29.0	29.0	(6.5)~－ [+29.4%]	16.3	+78.2%
      Net income per share attributable to OMRON shareholders (Yen)	180.30~ 147.29	147.40	(32.89)~+0.12	82.63	[+64.77]
      Average USD exchange rate (Yen)	140.0	145.7	+5.7	152.6	[-7.0]
      Average EUR exchange rate (Yen)	160.0	165.9	+5.9	163.7	[+2.2]
      Average CNY exchange rate (Yen)	20.0	20.2	+0.2	21.1	[-1.0]

      Note: Projected average rate for the full year based on historical rates for the first half and assumed exchange rates for the third quarter and later.

      Forecasts by Business Segment

      (Billions of yen, except percentages)

      		Initial forecast (Reclassified) (A)	Revised forecast (B)	Change in forecast (B-A) [%]	(Reference) Actual results for the prior fiscal year ended March 31, 2025 (Reclassified) (C)	(Reference) Percentage change from the prior fiscal year (B/C-1)
      IAB	Sales to external customers	371.0	386.0	+15.0 [+4.0%]	360.8	+7.0%
      	Operating income	40.0	40.0	- [－]	36.3	+10.3%
      HCB	Sales to external customers	150.0	140.0	(10.0) [-6.7%]	145.9	-4.0%
      	Operating income	18.5	14.5	(4.0) [-21.6%]	17.5	-17.1%
      SSB	Sales to external customers	150.0	150.0	- [－]	143.4	+4.6%
      	Operating income	18.5	20.0	+1.5 [+8.1%]	15.3	+30.3%
      DMB	Sales to external customers	110.0	115.0	+5.0 [+4.5%]	105.4	+9.1%
      	Operating income	4.0	4.0	- (－)	0.3	-
      DSB	Sales to external customers	50.5	51.0	+0.5 [+1.0%]	42.7	+19.3%
      	Operating income	5.0	5.0	- [－]	2.8	+76.7%
      Eliminations & Corporate	Sales to external customers	3.5	3.0	(0.5) [－]	3.5	-
      	Operating income (loss)	(21.0)	(23.5)	(2.5) [－]	(18.2)	-
      Risk of fluctuations in company-wide earnings	Sales to external customers	0.0~(15.0)	-	-	-	-
      	Operating income (loss)	0.0~(9.0)	-	-	-	-
      Consolidated	Sales to external customers	835.0~820.0	845.0	+10.0~+25.0 [+1.2~+3.0%]	801.8	+5.4%
      	Operating income	65.0~56.0	60.0	(5.0)~+4.0 [-7.7~+7.1%]	54.0	+11.0%

      Note: Effective the third quarter of this fiscal year, the results of OMRON DIGITAL Co., Ltd., previously recorded under SSB, will be recorded under Eliminations and Others in accordance with changes in management structure within the OMRON Group. Accordingly, beginning with the third quarter of the current consolidated fiscal year, we plan to present the results of the interim period of the current consolidated fiscal year and the previous fiscal year using the classifications after said change, which we have reflected in this revised forecast. We have reclassified our initial forecast and results for the previous period.

   4. Determination of Dividends (Interim Dividend) and Revision of Year-End Dividend Forecast

      At a meeting held today (November 7, 2025) the OMRON Corporation (TOKYO: 6645; ADR: OMRNY) board of directors resolved to approve a dividend from surplus (interim dividend) with a record date of September 30, 2025. The board also resolved to revise the year-end dividend forecast for the fiscal year ending March 31, 2026.

      Determination of Dividends (Interim Dividend)

      	Amount	Previous forecast (announced May 8, 2025)	Actual results for the prior fiscal year ended March 31, 2025
      Dividend record date	September 30, 2025	September 30, 2025	September 30, 2024
      Dividends per share	52.00 yen	-	52.00 yen
      Total dividends	10,263 million yen	-	10,266 million yen
      Effective date	December 2, 2025	-	December 3, 2024
      Source of dividends	Retained earnings	-	Retained earnings

      Revision of Year-End Dividend Forecast

      	Dividends per share
      Dividend record date	Interim	Year-end	Full-year
      Previous forecast (announced May 8, 2025)	-	-	104.00 yen
      Revised forecast	-	52.00 yen	104.00 yen
      Fiscal 2025 actual (ending March 31, 2026)	52.00 yen	-	-
      Fiscal 2024 actual (ended March 31, 2025)	52.00 yen	52.00 yen	104.00 yen

      Reasons for Revision

      As the interim dividend and the annual dividend are determined based on our cash allocation policy and shareholder return policy during the restructuring period, the annual dividend forecast will remain unchanged from the initial forecast of 104.00 yen. Our forecast of interim dividends and year-end dividends are 52.00 yen per share, respectively, each representing half of our full-year dividend forecast. These amounts are same year on year.

      Cash Allocation Policy During the Restructuring Period

      1. Aiming to maximize corporate value through the realization of the long-term vision, OMRON prioritizes the necessary investment to create new value from a medium- and long-term perspective. During our restructuring period (April 1, 2024 through September 30, 2025), we intend to concentrate group resources on Structural Reform Program NEXT2025, giving top priority to the investments necessary to restore business performance and restructure our foundation for earnings and growth. On this basis, OMRON will return profits to shareholders in a stable and sustainable manner.

      2. In principle, we will source the funds for these value-creating investments and shareholder returns through retained earnings and the sustained creation of operating cash flows. We will raise funds as needed, maintaining a degree of financial soundness to facilitate fund-raising regardless of financial market conditions.

         Shareholder Return Policy During the Restructuring Period

         1. We will prioritize investments necessary for value creation from a medium- to long-term perspective, establishing a dividend on equity (DOE) target of approximately 3% as a standard for annual dividends. Taking past dividend payments also into account, we intend to ensure stable and continuing shareholder returns.

         2. Having engaged in the investments and allocation of profits described above, we will distribute retained earnings accumulated over the long term to shareholders through opportunistic share buybacks and other measures.

         Beginning with the next fiscal year, we plan to determine profit distribution to shareholders based on the shareholder return policy under Medium-Term Roadmap SF 2nd Stage.

2. Interim Consolidated Financial Statements and Notes

   1. Interim Consolidated Balance Sheets

      (Millions of yen)

      	As of March 31, 2025		As of September 30, 2025		Increase (decrease)
      		%		%
      ASSETS
      Current assets:	539,336	39.6	560,136	40.0	20,800
      Cash and cash equivalents	149,023		160,595		11,572
      Notes and accounts receivable-trade	172,967		146,206		(26,761)
      Allowance for doubtful receivables	(1,263)		(1,315)		(52)
      Inventories	172,953		192,860		19,907
      Assets held for sale	-		4,534		4,534
      Other current assets	45,656		57,256		11,600
      Property, plant and equipment, net:	135,077	9.9	137,220	9.8	2,143
      Investments and other assets:	687,377	50.5	702,305	50.2	14,928
      Right-of-use assets under operating leases	47,023		46,543		(480)
      Goodwill	361,181		364,850		3,669
      Other intangible assets	115,236		122,810		7,574
      Investments in and advances to affiliates	15,799		13,677		(2,122)
      Investment securities	41,114		50,322		9,208
      Leasehold deposits	7,472		7,681		209
      Prepaid pension costs	63,578		64,139		561
      Deferred income taxes	27,503		25,550		(1,953)
      Other assets	8,471		6,733		(1,738)
      Total assets	1,361,790	100.0	1,399,661	100.0	37,871

      (Millions of yen)

      	As of March 31, 2025		As of September 30, 2025		Increase (decrease)
      		%		%
      LIABILITIES
      Current liabilities	233,283	17.1	261,530	18.7	28,247
      Notes and accounts payable-trade	91,620		97,182		5,562
      Short-term debt	20,372		42,778		22,406
      Accrued expenses	45,270		43,489		(1,781)
      Income taxes payable	6,705		5,852		(853)
      Short-term operating lease liabilities	12,807		13,206		399
      Liabilities held for sale	-		3,981		3,981
      Other current liabilities	56,509		55,042		(1,467)
      Deferred income taxes	16,273	1.2	16,797	1.2	524
      Termination and retirement benefits	8,279	0.6	8,167	0.6	(112)
      Long-term debt	119,088	8.7	123,277	8.8	4,189
      Long-term operating lease liabilities	31,936	2.4	31,008	2.2	(928)
      Other long-term liabilities	18,499	1.4	18,590	1.3	91
      Total liabilities	427,358	31.4	459,369	32.8	32,011
      NET ASSETS
      Shareholders' equity	771,885	56.7	777,807	55.6	5,922
      Common stock	64,100	4.7	64,100	4.6	-
      Capital surplus	100,161	7.4	99,550	7.1	(611)
      Legal reserve	29,471	2.2	32,055	2.3	2,584
      Retained earnings	550,485	40.4	546,723	39.1	(3,762)
      Accumulated other comprehensive income	97,632	7.2	105,873	7.5	8,241
      Foreign currency translation adjustments	88,186		96,314		8,128
      Pension liability adjustments	9,446		9,559		113
      Treasury stock	(69,964)	(5.2)	(70,494)	(5.0)	(530)
      Non controlling interests	162,547	11.9	162,485	11.6	(62)
      Total net assets	934,432	68.6	940,292	67.2	5,860
      Total liabilities and net assets	1,361,790	100.0	1,399,661	100.0	37,871

   2. Interim Consolidated Statements of Income and Interim Consolidated Statements of Comprehensive Income (Interim Consolidated Statements of Income) (Six months ended September 30, 2025)

      (Millions of yen)

      	Six months ended September 30, 2024		Six months ended September 30, 2025		Increase (decrease)
      		%		%
      Net sales	374,638	100.0	393,448	100.0	18,810
      Cost of sales	204,625	54.6	220,912	56.1	16,287
      Gross profit	170,013	45.4	172,536	43.9	2,523
      Selling, general and administrative expenses	129,188	34.5	129,174	32.9	(14)
      Research and development expenses	21,599	5.8	25,643	6.5	4,044
      Operating income	19,226	5.1	17,719	4.5	(1,507)
      Restructuring expenses	21,366	5.7	5,827	1.5	(15,539)
      Other income, net	(1,804)	(0.5)	(5,143)	(1.3)	(3,339)
      Income (loss) before income taxes	(336)	(0.1)	17,035	4.3	17,371
      Income taxes	2,329	0.6	5,852	1.5	3,523
      Share of loss (profit) of entities accounted for using equity method	(328)	(0.1)	1,226	0.3	1,554
      Net income (loss)	(2,337)	(0.6)	9,957	2.5	12,294
      Net income attributable to noncontrolling interests	981	0.3	910	0.2	(71)
      Net income (loss) attributable to OMRON shareholders	(3,318)	(0.9)	9,047	2.3	12,365

      (Interim Consolidated Statements of Comprehensive Income) (Six months ended September 30, 2025)

      (Millions of yen)

      	Six months ended September 30, 2024	Six months ended September 30, 2025	Increase (decrease)
      Net income (loss)	(2,337)	9,957	12,294
      Other comprehensive income, net of tax
      Foreign currency translation adjustments	(14,334)	8,203	22,537
      Pension liability adjustments	4,135	113	(4,022)
      Net losses on derivative instruments	(6)	-	6
      Other comprehensive income (loss)	(10,205)	8,316	18,521
      Comprehensive income (loss)	(12,542)	18,273	30,815
      (Breakdown)
      Comprehensive income attributable to noncontrolling interests Comprehensive income (loss) attributable to OMRON shareholders	900 (13,442)	985 17,288	85 30,730

   3. Interim Consolidated Statements of Cash Flows

      (Millions of yen)

      	Six months ended September 30, 2024		Six months ended September 30, 2025
      Ⅰ Operating Activities:
      1. Net income (loss)		(2,337)		9,957
      2. Adjustments to reconcile net income (loss) to net cash provided by
      operating activities:
      (1) Depreciation and amortization	16,826		16,499
      (2) Share of loss (profit) of entities accounted for using equity method	(328)		1,226
      (3) Gain on valuation of investment securities	(83)		(7,633)
      (4) Decrease in notes and accounts receivable － trade	33,881		28,855
      (5) Increase in inventories	(10,732)		(18,398)
      (6) Increase (decrease) in notes and accounts payable － trade	(6,179)		5,869
      (7) Other, net	(7,203)	26,182	(8,389)	18,029
      Net cash provided by operating activities		23,845		27,986
      Ⅱ Investing Activities:
      1. Purchases of investment securities		(1,552)		(370)
      2. Capital expenditures		(22,180)		(23,036)
      3. Business and company acquisitions (net of cash acquired)		(4,540)		(4,715)
      4. Other, net		(1,479)		639
      Net cash used in investing activities		(29,751)		(27,482)
      (Reference) Free cash flow		(5,906)		504
      Ⅲ Financing Activities:
      1. Increase in short-term debt with maturities of three months or less, net		26,313		21,139
      2. Proceeds from short-term debt with maturities longer than three months		1,500		1,160
      3. Repayments of short-term debt with maturities longer than three months		(2,883)		(1,200)
      4. Proceeds from long-term debt		12,708		5,745
      5. Repayments of long-term debt		(2,917)		(2,304)
      6. Purchase of treasury shares		(4)		(1,318)
      7. Dividends paid by OMRON Corporation		(10,236)		(10,237)
      8. Dividends paid to noncontrolling interests		(1,466)		(1,267)
      9. Other, net		(114)		348
      Net cash provided by financing activities		22,901		12,066
      Ⅳ Effect of Exchange Rate Changes on Cash and Cash Equivalents		1,257		1,253
      Cash and cash equivalents included in assets held for sale		-		(2,251)
      Net increase in cash and cash equivalents		18,252		11,572
      Cash and cash equivalents at beginning of the period		143,086		149,023
      Cash and cash equivalents at end of the period		161,338		160,595

      Note: Free cash flow is cash flow from operating activities plus cash flow from investing activities.

   4. Notes Regarding Consolidated Financial Statements

None applicable

None applicable

ASC 280, "Segment Reporting," establishes the disclosure of information about operating segments in financial statements. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the president and CEO, the Company's chief operating decision maker (CODM), in deciding how to allocate resources and in assessing performance. The CODM use segment income or loss to allocate resources to each segment and to assess comparison between plans and actual results in evaluating business performance of segments.

The Company discloses operating segment information in five operating segments: "IAB," "HCB," "SSB," "DMB," and "DSB". These segments are mainly separated based on the Companies' consideration of their nature of the products and the business standing in the group.

The primary products included in each segment are as follows:

1. IAB: Industrial Automation Business

   ……Programmable controllers, motion controllers, sensing devices, industrial camera/code reader devices, inspection systems, safety devices and industrial robots

2. HCB: Healthcare Business

   ……Digital blood pressure monitors, nebulizers, low-frequency therapy equipment, ECGs, oxygen concentrators, digital thermometers, body composition monitors, pedometers and activity meters, electric toothbrushes, massagers, blood glucose monitors, vascular screening devices, visceral fat monitors, remote patient monitoring systems and telemedicine service

3. SSB: Social Systems, Solutions and Service Business

   ……Energy business (solar power generation, storage battery systems), railway station service systems, traffic and road management systems, card payment services, IoT (power protection, data protection) solutions, software development and comprehensive maintenance service business

4. DMB: Devices & Module Solutions Business

   ……Relays, switches, connectors, IoT communication modules, general sensors, amusement components and units, face recognition software, image sensing component and MEMS(Note)sensors

   Note: MEMS: Micro Electro Mechanical Systems

5. DSB: Data Solution Business

   ……Data healthcare business, corporate health business, smart M&S (management service solutions) business, carbon neutral solutions business, data-based solutions business, and self-reliance support business

   The segment information is presented in accordance with accounting principles generally accepted in the United States of America.

   Revenues and expenses directly associated with specific segments are disclosed in the figures of each segment's operating results. Based on the Company's allocation method used by management to evaluate results of each segment, revenues and expenses not directly associated with specific segments are allocated to each segment or included in "Eliminations and Others."

   Segment income is presented as gross profit less selling, general and administrative expenses and research and development expenses. Restructuring expenses, other income, net, income taxes, share of loss (profit) of entities accounted for using equity method are not deducted.

   Business Segment Information

   Six months ended September 30, 2024 (April 1, 2024 - September 30, 2024)

   (Millions of yen)

   	IAB	HCB	SSB	DMB	DSB	Total	Eliminations and Others	Consolidated
   Sales
   1. Sales to external customers	174,465	72,503	56,885	51,098	19,088	374,039	599	374,638
   2. Intersegment sales	2,278	201	5,426	17,560	158	25,623	(25,623)	-
   Total	176,743	72,704	62,311	68,658	19,246	399,662	(25,024)	374,638
   Materials costs	21,704	30,623	16,927	28,194	403	97,851	1,118	98,969
   Labor costs	49,840	13,155	16,983	18,425	8,111	106,514	9,802	116,316
   Other operating expenses	87,822	20,321	26,446	21,943	10,395	166,927	(26,800)	140,127
   Segment income	17,377	8,605	1,955	96	337	28,370	(9,144)	19,226

   Notes: 1. The value of intersegment transactions is in accordance with the value of transactions with external customers.

   1. The DSB includes financial figures related to the OMRON Data Solution Business and JMDC financial figures, as well as the amortization of intangible assets other than goodwill identified as a result of the consolidation of JMDC as a subsidiary.

   2. "Eliminations and Others" include not allocated expenses and eliminations of intersegment transactions and the head office divisions and others.

   3. Other operating expenses include expenses included in selling, general and administrative expenses and research and development expenses. The account also includes expenses other than materials costs and labor costs, which are a constituent of cost of sales.

Six months ended September 30, 2025 (April 1, 2025 - September 30, 2025)

(Millions of yen)

Notes: 1. The value of intersegment transactions is in accordance with the value of transactions with external customers.

2. The DSB includes financial figures related to the OMRON Data Solution Business and JMDC financial figures, as well as the amortization of intangible assets other than goodwill identified as a result of the consolidation of JMDC as a subsidiary.

1. "Eliminations and Others" include not allocated expenses and eliminations of intersegment transactions and the head office divisions and others.

2. Other operating expenses include expenses included in selling, general and administrative expenses and research and development expenses. The account also includes expenses other than materials costs and labor costs, which are a constituent of cost of sales.

The reconciliations of total segment income to income (loss) before income taxes for the six months ended September 30, 2024 and 2025 are as follows.

(Millions of yen)